Latest Articles
The Link Between Cancer and Endometriosis You Need to Know About - Well+Good
The Link Between Cancer and Endometriosis You Need to Know About Well+Good
Published: Feb. 5, 2025, 3:33 p.m.
A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting - Cureus
A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting Cureus
Published: Feb. 5, 2025, 1:26 p.m.
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer The Manila Times
Published: Feb. 5, 2025, 1:07 p.m.
Acrivon's AI-Powered Cancer Test Achieves 62.5% Response Rate, Earns FDA Breakthrough Status - StockTitan
Acrivon's AI-Powered Cancer Test Achieves 62.5% Response Rate, Earns FDA Breakthrough Status StockTitan
Published: Feb. 5, 2025, 1 p.m.
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron - Nature.com
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron Nature.com
Published: Feb. 5, 2025, 11:37 a.m.
Cancer risk could increase by hot water bottle use, doctor warns - Gloucestershire Live
Cancer risk could increase by hot water bottle use, doctor warns Gloucestershire Live
Published: Feb. 4, 2025, 1:40 p.m.
Doctor issues urgent cancer warning over hot water bottles - don't do this - The Mirror
Doctor issues urgent cancer warning over hot water bottles - don't do this The Mirror
Published: Feb. 4, 2025, 1:31 p.m.
Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab - Physician's Weekly
Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab Physician's Weekly
Published: Feb. 4, 2025, 11:09 a.m.
Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program - AboutLawsuits.com
Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program AboutLawsuits.com
Published: Feb. 3, 2025, 9:15 p.m.
Endometrial Cancer and Mental Health: Challenges and Finding Support - Healthline
Endometrial Cancer and Mental Health: Challenges and Finding Support Healthline
Published: Feb. 3, 2025, 5:51 p.m.
Link copied to clipboard!